Target intelligence / Profile preview

RNA, U6 small nuclear 1049, pseudogene (RNU6-1049P)

Target
RNU6-1049P
Molecular classification
Other (Pseudogene)
01

Overview

RNU6-1049P refers to a pseudogene of the U6 small nuclear RNA gene, specifically the "RNA, U6 small nuclear 1049, pseudogene." As a pseudogene, RNU6-1049P is a non-coding segment of DNA that resembles the functional U6 small nuclear RNA gene but is typically not transcribed into a functional product. U6 small nuclear RNA itself is an essential component of the spliceosome and mediates pre-mRNA splicing, but pseudogenes like RNU6-1049P are not functionally active in this process. There is no evidence linking RNU6-1049P to drug interactions, biological functions, or disease involvement. It should not be considered a therapeutic target or functional gene. The designation "pseudogene" indicates a genomic sequence related to a functional gene that has lost its gene expression or protein-coding capability, typically due to mutations or other genomic changes. In this case, RNU6-1049P is similar in sequence to the active U6 snRNA gene but does not encode a functional RNA product. There is nothing to suggest a role for this pseudogene in common disease or therapeutic targeting. Some pseudogenes elsewhere may function as competitive endogenous RNAs or have regulatory effects, but this is not documented for RNU6-1049P and is not typical for U6 pseudogenes specifically.

Other names
RNU6-1049P

Beyond the preview

Go deeper on RNA, U6 small nuclear 1049, pseudogene (RNU6-1049P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1049, pseudogene (RNU6-1049P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call